Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Salvarani

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Neurology|June 11, 2008
Primary CNS vasculitis with spinal cord involvementC Salvarani, R D Brown, K T Calamia, et al.
Rheumatology (Oxford, England)|August 30, 2008
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathyC Salvarani, R D Brown, K T Calamia, et al.
Clinical and Experimental Rheumatology|February 13, 2010
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methodsE Lubrano, A Marchesoni, I Olivieri, et al.
Annals of the Rheumatic Diseases|January 23, 2008
Cervical interspinous bursitis in active polymyalgia rheumaticaC Salvarani, L Barozzi, F Cantini, et al.
Clinical and Experimental Immunology|December 17, 2018
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritisC Felice, P Leccese, L Scudeller, et al.
Clinical and Experimental Rheumatology|August 4, 2009
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritisL Boiardi, B Casali, E Farnetti, et al.
The Journal of Rheumatology|August 18, 2001
Association of MICA alleles and HLA-B51 in Italian patients with Behçet's diseaseC Salvarani, L Boiardi, V Mantovani, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
Annals of the Rheumatic Diseases|August 21, 2007
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritisC Salvarani, B Casali, E Farnetti, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
Adalimumab in the treatment of immune-mediated diseasesG Lapadula, A Marchesoni, A Armuzzi, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Neurology|June 11, 2008
Primary CNS vasculitis with spinal cord involvementC Salvarani, R D Brown, K T Calamia, et al.
Rheumatology (Oxford, England)|August 30, 2008
Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathyC Salvarani, R D Brown, K T Calamia, et al.
Clinical and Experimental Rheumatology|February 13, 2010
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methodsE Lubrano, A Marchesoni, I Olivieri, et al.
Annals of the Rheumatic Diseases|January 23, 2008
Cervical interspinous bursitis in active polymyalgia rheumaticaC Salvarani, L Barozzi, F Cantini, et al.
Clinical and Experimental Immunology|December 17, 2018
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritisC Felice, P Leccese, L Scudeller, et al.
Clinical and Experimental Rheumatology|August 4, 2009
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritisL Boiardi, B Casali, E Farnetti, et al.
The Journal of Rheumatology|August 18, 2001
Association of MICA alleles and HLA-B51 in Italian patients with Behçet's diseaseC Salvarani, L Boiardi, V Mantovani, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumabA Armuzzi, P Lionetti, C Blandizzi, et al.
Annals of the Rheumatic Diseases|August 21, 2007
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritisC Salvarani, B Casali, E Farnetti, et al.
International Journal of Immunopathology and Pharmacology|April 30, 2014
Adalimumab in the treatment of immune-mediated diseasesG Lapadula, A Marchesoni, A Armuzzi, et al.
Pageof 24